Valuation Ipsen

Stocks

Market Closed - Euronext Paris 16:55:00 30/10/2026 GMT			5-day change	1st Jan Change
157.60 ^EUR	+1.16%		+4.23%	+32.44%

10-22	Ipsen: Better-than-expected Q3 overshadowed by 2027 Somatuline erosion and arbitration risk
10-22	Ipsen S.A. Upgrades Financial Guidance for the Full-Year 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	12,922	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	32.26%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	11,414	10,491	9,471
Change	-	16.81%	12.22%	1.81%	2.28%	23.72%	-8.08%	-9.73%
P/E	10.4x	12.9x	14x	26.7x	22.4x	11.6x	12.9x	13.4x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.63x	2.18x	1.89x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	-1.31x	-4.05x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	2.81x	2.73x	2.65x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.48x	2.21x	1.94x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	5.69x	5.61x	5.14x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	6.63x	6.71x	6.22x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	9.27x	8.42x	7.47x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	10.8%	11.9%	13.4%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.431	1.553	1.652
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	0.91%	0.99%	1.05%
EPS ²	7.76	7.81	7.73	4.15	5.32	13.53	12.2	11.8
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	10.6%	12.7%	14%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,601	4,739	4,871
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	2,006	1,869	1,841
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,723	1,564	1,523
Net income ¹	646.6	647.5	647.2	347.3	444.5	1,144	1,052	1,013
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,508	-2,430	-3,451
Reference price ²	80.50	100.50	107.90	110.70	119.00	157.60	157.60	157.60
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	81,990	-	-
Announcement Date	11/02/22	09/02/23	08/02/24	13/02/25	12/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IPSEN	11.65x	2.48x	5.69x	0.91%	14.43B
ELI LILLY AND COMPANY	41.54x	14.06x	31.11x	0.48%	1,263B
JOHNSON & JOHNSON	39.99x	6.71x	18.89x	1.95%	658B
ABBVIE INC.	38.61x	8.62x	17.83x	2.33%	521B
ROCHE HOLDING AG	21.74x	5.27x	13.12x	2.48%	391B
MERCK & CO., INC.	109.15x	6.06x	25.73x	2.28%	369B
NOVARTIS AG	23.19x	5.97x	14.41x	2.71%	307B
ASTRAZENECA PLC	24.47x	4.9x	13.63x	1.77%	290B
AMGEN INC.	29.56x	7.53x	13.48x	2.16%	252B
GILEAD SCIENCES, INC.	-49.1x	7.47x	29.35x	1.93%	212B
Average	29.08x	6.91x	18.32x	1.9%	427.64B
Weighted average by Cap.	37.20x	8.82x	21.91x	1.69%